Figure 3, representing only NKI cases (n = 106), shows that lesions categorised as grade 1 DCIS by the majority opinion were all ER positive and HER2 negative, and those categorised as grade 2 were predominantly ER positive (100%) and HER2 negative (88%). The gene discussed is ERBB2; the disease is ductal breast carcinoma in situ.